277 related articles for article (PubMed ID: 18778938)
1. Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors.
Guckian KM; Lin EY; Silvian L; Friedman JE; Chin D; Scott DM
Bioorg Med Chem Lett; 2008 Oct; 18(19):5249-51. PubMed ID: 18778938
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors.
Lin EY; Guckian KM; Silvian L; Chin D; Boriack-Sjodin PA; van Vlijmen H; Friedman JE; Scott DM
Bioorg Med Chem Lett; 2008 Oct; 18(19):5245-8. PubMed ID: 18783948
[TBL] [Abstract][Full Text] [Related]
3. Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold.
Dodd DS; Sheriff S; Chang CJ; Stetsko DK; Phillips LM; Zhang Y; Launay M; Potin D; Vaccaro W; Poss MA; McKinnon M; Barrish JC; Suchard SJ; Murali Dhar TG
Bioorg Med Chem Lett; 2007 Apr; 17(7):1908-11. PubMed ID: 17291752
[TBL] [Abstract][Full Text] [Related]
4. Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors.
Anderson M; Andrews DM; Barker AJ; Brassington CA; Breed J; Byth KF; Culshaw JD; Finlay MR; Fisher E; McMiken HH; Green CP; Heaton DW; Nash IA; Newcombe NJ; Oakes SE; Pauptit RA; Roberts A; Stanway JJ; Thomas AP; Tucker JA; Walker M; Weir HM
Bioorg Med Chem Lett; 2008 Oct; 18(20):5487-92. PubMed ID: 18815031
[TBL] [Abstract][Full Text] [Related]
5. Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).
Emmitte KA; Wilson BJ; Baum EW; Emerson HK; Kuntz KW; Nailor KE; Salovich JM; Smith SC; Cheung M; Gerding RM; Stevens KL; Uehling DE; Mook RA; Moorthy GS; Dickerson SH; Hassell AM; Leesnitzer MA; Shewchuk LM; Groy A; Rowand JL; Anderson K; Atkins CL; Yang J; Sabbatini P; Kumar R
Bioorg Med Chem Lett; 2009 Feb; 19(3):1004-8. PubMed ID: 19101143
[TBL] [Abstract][Full Text] [Related]
6. Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.
Gong Y; Barbay JK; Buntinx M; Li J; Wauwe JV; Claes C; Lommen GV; Hornby PJ; He W
Bioorg Med Chem Lett; 2008 Jul; 18(14):3852-5. PubMed ID: 18595693
[TBL] [Abstract][Full Text] [Related]
7. 1,4-Diazepane-2-ones as novel inhibitors of LFA-1.
Wattanasin S; Albert R; Ehrhardt C; Roche D; Sabio M; Hommel U; Welzenbach K; Weitz-Schmidt G
Bioorg Med Chem Lett; 2003 Feb; 13(3):499-502. PubMed ID: 12565959
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3.
Swahn BM; Xue Y; Arzel E; Kallin E; Magnus A; Plobeck N; Viklund J
Bioorg Med Chem Lett; 2006 Mar; 16(5):1397-401. PubMed ID: 16337120
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors.
Holsworth DD; Jalaie M; Belliotti T; Cai C; Collard W; Ferreira S; Powell NA; Stier M; Zhang E; McConnell P; Mochalkin I; Ryan MJ; Bryant J; Li T; Kasani A; Subedi R; Maiti SN; Edmunds JJ
Bioorg Med Chem Lett; 2007 Jul; 17(13):3575-80. PubMed ID: 17482464
[TBL] [Abstract][Full Text] [Related]
10. The signature molecular descriptor. 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides.
Churchwell CJ; Rintoul MD; Martin S; Visco DP; Kotu A; Larson RS; Sillerud LO; Brown DC; Faulon JL
J Mol Graph Model; 2004 Mar; 22(4):263-73. PubMed ID: 15177078
[TBL] [Abstract][Full Text] [Related]
11. Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.
Ullrich T; Baumann K; Welzenbach K; Schmutz S; Camenisch G; Meingassner JG; Weitz-Schmidt G
Bioorg Med Chem Lett; 2004 May; 14(10):2483-7. PubMed ID: 15109637
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening leads to the discovery of an effective antagonist of lymphocyte function-associated antigen-1.
Shoda M; Harada T; Yano K; Stahura FL; Himeno T; Shiojiri S; Kogami Y; Kouji H; Bajorath J
ChemMedChem; 2007 Apr; 2(4):515-21. PubMed ID: 17340656
[TBL] [Abstract][Full Text] [Related]
13. Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists.
Zhong M; Shen W; Barr KJ; Arbitrario JP; Arkin MR; Bui M; Chen T; Cunningham BC; Evanchik MJ; Hanan EJ; Hoch U; Huen K; Hyde J; Kumer JL; Lac T; Lawrence CE; Martell JR; Oslob JD; Paulvannan K; Prabhu S; Silverman JA; Wright J; Yu CH; Zhu J; Flanagan WM
Bioorg Med Chem Lett; 2010 Sep; 20(17):5269-73. PubMed ID: 20655213
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
[TBL] [Abstract][Full Text] [Related]
15. Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling.
Zheng M; Zheng M; Ye D; Deng Y; Qiu S; Luo X; Chen K; Liu H; Jiang H
Bioorg Med Chem Lett; 2007 May; 17(9):2414-20. PubMed ID: 17336065
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.
Raza A; Sham YY; Vince R
Bioorg Med Chem Lett; 2008 Oct; 18(20):5406-10. PubMed ID: 18829317
[TBL] [Abstract][Full Text] [Related]
17. Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.
Eary CT; Jones ZS; Groneberg RD; Burgess LE; Mareska DA; Drew MD; Blake JF; Laird ER; Balachari D; O'Sullivan M; Allen A; Marsh V
Bioorg Med Chem Lett; 2007 May; 17(9):2608-13. PubMed ID: 17331716
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure based optimization of novel Akt inhibitors.
Lippa B; Pan G; Corbett M; Li C; Kauffman GS; Pandit J; Robinson S; Wei L; Kozina E; Marr ES; Borzillo G; Knauth E; Barbacci-Tobin EG; Vincent P; Troutman M; Baker D; Rajamohan F; Kakar S; Clark T; Morris J
Bioorg Med Chem Lett; 2008 Jun; 18(11):3359-63. PubMed ID: 18456494
[TBL] [Abstract][Full Text] [Related]
19. Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interaction.
Nam K; Maiorov V; Feuston B; Kearsley S
Proteins; 2006 Aug; 64(2):376-84. PubMed ID: 16705652
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles.
McAtee JJ; Dodson JW; Dowdell SE; Erhard K; Girard GR; Goodman KB; Hilfiker MA; Jin J; Sehon CA; Sha D; Shi D; Wang F; Wang GZ; Wang N; Wang Y; Viet AQ; Yuan CC; Zhang D; Aiyar NV; Behm DJ; Carballo LH; Evans CA; Fries HE; Nagilla R; Roethke TJ; Xu X; Douglas SA; Neeb MJ
Bioorg Med Chem Lett; 2008 Jul; 18(13):3716-9. PubMed ID: 18524591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
